跳至主要内容
临床试验/NCT04220970
NCT04220970招募中不适用

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

The Lymphoma Academic Research Organisation31 个研究点 分布在 2 个国家目标入组 150 人开始时间: 2017年6月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150
试验地点
31
主要终点
Overall response

研究概览

简要总结

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant.

Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a BIA-ALCL case registry, in connection with a national Multidisciplinary meeting (Réunion de Concertation Pluridisciplinaire nationale de recours- RCP).

This registry is opened in France and in Belgium

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult patients with an anaplastic large cell lymphoma associated with breast implants

排除标准

  • 未提供

研究组 & 干预措施

BIA-ALCL

干预措施: BIA-ALCL (Other)

结局指标

主要结局

Overall response

时间窗: 13 years

次要结局

未报告次要终点

研究者

发起方
The Lymphoma Academic Research Organisation
申办方类型
Other
责任方
Sponsor

研究点 (31)

Loading locations...

相似试验

Breast Implant-associated Anaplastic Large Cell... | 临床试验